CORT
CORCEPT THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$79.22
−3.31%Next report
Analyst consensus
- Next report date
- Feb 23, 2027
- EPS estimate
- $1.05
- Revenue estimate
- $384.1M
Latest reported
- Last report date
- Nov 3, 2026
- EPS actual
- $1.01
- EPS estimate
- $0.79
- Revenue actual
- $340.5M
- Revenue estimate
- $336.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +315.0%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Nov 3, 2026 | $0.84 | $1.01 | Beat 20.24% | $340.5M |
| Jul 29, 2026 | $0.02 | $0.36 | Beat 1383.31% | $256.1M |
| Apr 30, 2026 | -$0.14 | -$0.30 | Miss -111.27% | $164.9M |
| Feb 24, 2026 | $0.33 | $0.20 | Miss -39.39% | $202.1M |
| Nov 4, 2025 | $0.18 | $0.16 | Miss -11.11% | $207.6M |
| Jul 31, 2025 | $0.23 | $0.29 | Beat 26.09% | $194.4M |
| Feb 26, 2025 | $0.37 | $0.26 | Miss -29.73% | $181.9M |
| Oct 30, 2024 | $0.28 | $0.41 | Beat 46.43% | $182.5M |
| May 1, 2024 | $0.22 | $0.25 | Beat 14.16% | $146.8M |
| Feb 15, 2024 | $0.26 | $0.28 | Beat 8.95% | $135.4M |
| Nov 1, 2023 | $0.22 | $0.28 | Beat 26.70% | $123.6M |
| Aug 2, 2023 | $0.15 | $0.25 | Beat 65.56% | $117.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 23, 2027